Novartis recently signed a new contract with Hanmi Pharmaceutical as their co-sales contract with Handok ends

On July 9, according to the related industry, Novartis recently signed a new contract with Hanmi Pharmaceutical as their co-sales contract of 'Galvus (vildagliptin)' and metformin complex 'Galvusmet' with Handok ends.

Galvus and Januvia vied for first place. However, after the release of Trajenta, its sales are slowing down. Thus, Hanmi Pharmaceutical has the top-level sales force in the count...